{"name": "Springleaf Therapeutics",
 "permalink": "springleaf-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/springleaf-therapeutics",
 "homepage_url": "http://www.springleaftx.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@springleaftx.com",
 "phone_number": "1-617-358-4927",
 "description": "",
 "created_at": "Thu May 12 08:23:51 UTC 2011",
 "updated_at": "Thu Sep 20 04:11:01 UTC 2012",
 "overview": "\u003Cp\u003ESpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf\u00e2\u20ac\u2122s technology is based on convergent science and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Flybridge Capital Partners and North Bridge Venture Partners.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       48],
      "assets/images/resized/0013/4279/134279v1-max-150x150.jpg"],
     [[250,
       80],
      "assets/images/resized/0013/4279/134279v1-max-250x250.jpg"],
     [[327,
       105],
      "assets/images/resized/0013/4279/134279v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Pieter",
      "last_name": "Muntendam",
      "permalink": "pieter-muntendam",
      "image": null}},
   {"is_past": false,
    "title": "Director ",
    "person":
     {"first_name": "Kurt",
      "last_name": "Graves",
      "permalink": "kurt-graves",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$19M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.masshightech.com/stories/2011/05/09/daily34-SpringLeaf-Therapeutics-raises-15M-Series-B-round.html",
    "source_description": "SpringLeaf Therapeutics raises $15M Series B round",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 5,
    "funded_day": 12,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SR One",
         "permalink": "sr-one",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Flybridge Capital Partners",
         "permalink": "flybridge-capital",
         "image":
          {"available_sizes":
            [[[150,
               53],
              "assets/images/resized/0002/3209/23209v2-max-150x150.jpg"],
             [[229,
               82],
              "assets/images/resized/0002/3209/23209v2-max-250x250.jpg"],
             [[229,
               82],
              "assets/images/resized/0002/3209/23209v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "North Bridge Venture Partners",
         "permalink": "north-bridge-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0001/0794/10794v1-max-150x150.png"],
             [[250,
               70],
              "assets/images/resized/0001/0794/10794v1-max-250x250.png"],
             [[257,
               72],
              "assets/images/resized/0001/0794/10794v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.springleaftx.com/docs/Press-Release-2011-07-08-SpringLeaf-Announces-Second-Close-of-Series-B.pdf",
    "source_description": "SpringLeaf Therapeutics Announces Second Close of Series B Financing",
    "raised_amount": 4000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 7,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Excel Venture Management",
         "permalink": "excel-venture-management",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0010/1993/101993v1-max-150x150.jpg"],
             [[250,
               29],
              "assets/images/resized/0010/1993/101993v1-max-250x250.jpg"],
             [[450,
               52],
              "assets/images/resized/0010/1993/101993v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "8 St. Mary's Street",
    "address2": "Suite 601",
    "zip_code": "02215",
    "city": "Boston",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        108],
       "assets/images/resized/0013/4280/134280v1-max-150x150.jpg"],
      [[250,
        180],
       "assets/images/resized/0013/4280/134280v1-max-250x250.jpg"],
      [[450,
        325],
       "assets/images/resized/0013/4280/134280v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}